Supreme Court of Canada Rules in Favour of Theratechnologies
(firmenpresse) - MONTREAL, CANADA -- (Marketwired) -- 04/17/15 -- Theratechnologies Inc. (TSX: TH) announced today that the Supreme Court of Canada has granted its appeal and dismissed 121851 Canada Inc.'s motion for leave to commence an action based on the secondary market liability provisions of the Securities Act (Quebec) against Theratechnologies, one of its directors and a former president and chief executive officer.
The judgment reverses the July 17, 2013 decision of the Court of Appeal of Quebec confirming the February 24, 2012 decision issued by the Superior Court of Quebec authorizing 121851 Canada Inc., the representative of persons who were shareholders on May 21, 2010 and who sold their common shares of the Company on May 25 or 26, 2010, to institute a class action against the Company, one of its directors and a former president and chief executive officer.
As a result of the Company's motion being allowed, 121851 Canada Inc. may no longer initiate class action proceedings against the Company, one of its directors and a former president and chief executive officer under the Securities Act (Quebec). However, this decision does not impact the currently suspended civil law claim filed by 121851 Canada Inc. against Theratechnologies, one of its directors and a former president and chief executive officer based on the same facts and seeking the same conclusions as those sought under the class action lawsuit filed under the Securities Act (Quebec).
Theratechnologies will not make any additional comments on the decision issued today by the Supreme Court of Canada.
About Theratechnologies
Theratechnologies (TSX: TH) is a specialty pharmaceutical company addressing unmet medical needs in metabolic disorders to promote healthy ageing and improved quality of life. Further information about Theratechnologies is available on the Company's website at and on SEDAR at .
Contacts:
Jocelyn Lafond
Vice President, Legal Affairs, and Corporate Secretary
514-843-2393
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 17.04.2015 - 14:07 Uhr
Sprache: Deutsch
News-ID 386595
Anzahl Zeichen: 0
contact information:
Town:
MONTREAL, CANADA
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 227 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Supreme Court of Canada Rules in Favour of Theratechnologies"
steht unter der journalistisch-redaktionellen Verantwortung von
Theratechnologies Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
